Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTO

Proteon Therapeutics (PRTO) Stock Price, News & Analysis

Proteon Therapeutics logo

About Proteon Therapeutics Stock (NASDAQ:PRTO)

Advanced Chart

Key Stats

Today's Range
$3.01
$3.28
50-Day Range
$0.84
$25.13
52-Week Range
$0.22
$3.94
Volume
301,874 shs
Average Volume
1.11 million shs
Market Capitalization
$67.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PRTO Stock News Headlines

ProQR Therapeutics price target raised to $4 from $2.50 at Chardan
Protara Therapeutics (TARA) Earnings Dates & Reports
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
ProQR Therapeutics upgraded to Strong Buy from Outperform at Raymond James
ProQR Announces Major Share Offering Agreement
See More Headlines

PRTO Stock Analysis - Frequently Asked Questions

Proteon Therapeutics Inc (NASDAQ:PRTO) released its quarterly earnings results on Thursday, October, 31st. The biopharmaceutical company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteon Therapeutics investors own include Bristol Myers Squibb (BMY), SCYNEXIS (SCYX), Agile Therapeutics (AGRX), ImmunoGen (IMGN), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
10/31/2019
Today
8/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PRTO
CIK
1359931
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-118.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.98
Quick Ratio
5.98

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-51.67

Miscellaneous

Outstanding Shares
22,179,000
Free Float
N/A
Market Cap
$68.75 million
Optionable
Not Optionable
Beta
0.60
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:PRTO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners